BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Gkolfinopoulos S, Tsapakidis K, Papadimitriou K, Papamichael D, Kountourakis P. Chromogranin A as a valid marker in oncology: Clinical application or false hopes? World J Methodol 2017; 7(1): 9-15 [PMID: 28396845 DOI: 10.5662/wjm.v7.i1.9]
URL: https://www.wjgnet.com/1007-9327/full/v7/i1/9.htm
Number Citing Articles
1
Ambreen A. Merchant, Anna M. Goebel, Field F. Willingham. Radiofrequency ablation for the management of pancreatic mass lesionsCurrent Opinion in Gastroenterology 2023; 39(5): 448 doi: 10.1097/MOG.0000000000000939
2
Thorvardur R. Halfdanarson, Jonathan R. Strosberg, Laura Tang, Andrew M. Bellizzi, Emily K. Bergsland, Thomas M. O'Dorisio, Daniel M. Halperin, Lauren Fishbein, Jennifer Eads, Thomas A. Hope, Simron Singh, Riad Salem, David C. Metz, Boris G. Naraev, Diane L. Reidy-Lagunes, James R. Howe, Rodney F. Pommier, Yusuf Menda, Jennifer A. Chan. The North American Neuroendocrine Tumor Society Consensus Guidelines for Surveillance and Medical Management of Pancreatic Neuroendocrine TumorsPancreas 2020; 49(7): 863 doi: 10.1097/MPA.0000000000001597
3
Joyce Cheng, Ghanshyam Patel , Altaf Dawood, Ammar Aqeel. Gastric and Duodenal Neuroendocrine Tumor Incidentally Found on Endoscopy During the Evaluation of Iron-Deficiency AnemiaCureus 2022;  doi: 10.7759/cureus.22208
4
Akeem R. Lewis, Brian A. Costello, Fernando Quevedo, Lance C. Pagliaro, Cristobal Sanhueza, Richard M. Weinshilboum, Krishna R. Kalari, Liewei Wang, Manish Kohli, Winston Tan, Karthik V. Giridhar. Dynamic assessment of serum chromogranin A and treatment response with abiraterone acetate in metastatic castration‐resistant prostate cancerThe Prostate 2023; 83(7): 649 doi: 10.1002/pros.24498
5
Halyna Chytaieva , Bohdana Shkurupii , Liubov Zakhartseva . Correlation between expression of immunohistochemical markers and morphology in lung neuroendocrine neoplasmsUkrainian Scientific Medical Youth Journal 2022; 128(1): 6 doi: 10.32345/USMYJ.1(128).2022.6-18
6
Shadin Ghabra, Tracey Pu, Naris Nilubol, Andrew Mannes, Ning Miao. Anesthesia for Oncological Surgery2023; : 341 doi: 10.1007/978-3-031-50977-3_52
7
Karthik V. Giridhar, Cristobal Sanhueza, David W Hillman, Hassan Alkhateeb, Rachel Carlson, Winston Tan, Brian A. Costello, Fernando Quevedo, Lance Pagliaro, Manish Kohli. Serum chromogranin-A-based prognosis in metastatic castration-resistant prostate cancerProstate Cancer and Prostatic Diseases 2018; 21(3): 431 doi: 10.1038/s41391-018-0046-9
8
Ko‐Chao Lee, Hong‐Hwa Chen, Kung‐Chuan Cheng, Ting‐Ting Liu, Kam‐Fai Lee, Chih‐Chuan Teng, Cheng‐Yi Huang, Meng‐Chiao Hsieh, Hsing‐Chun Kuo. Use of iTRAQ‐based quantitative proteomic identification of CHGA and UCHL1 correlated with lymph node metastasis in colorectal carcinomaJournal of Cellular and Molecular Medicine 2023; 27(14): 2004 doi: 10.1111/jcmm.17793
9
Kristin Henry. Paraneoplastic syndromes: Definitions, classification, pathophysiology and principles of treatmentSeminars in Diagnostic Pathology 2019; 36(4): 204 doi: 10.1053/j.semdp.2019.01.002
10
Antoine Hollebecque, Stefania Salvagni, Ruth Plummer, Patricia Niccoli, Jaume Capdevila, Giuseppe Curigliano, Victor Moreno, Filippo de Braud, Sonia Gonzalez de Villambrosia, Patricia Martin‐Romano, Eric Baudin, Marina Arias, Juan de Alvaro, Josep L. Parra‐Palau, Tania Sánchez‐Pérez, Ida Aronchik, Ellen H. Filvaroff, Manisha Lamba, Zariana Nikolova, Johann S. de Bono. Clinical activity of CC‐90011, an oral, potent, and reversible LSD1 inhibitor, in advanced malignanciesCancer 2022; 128(17): 3185 doi: 10.1002/cncr.34366
11
Wei-Yu Chen, Phan Vu Thuy Dung, Hsiu-Lien Yeh, Wei-Hao Chen, Kuo-Ching Jiang, Han-Ru Li, Zi-Qing Chen, Michael Hsiao, Jiaoti Huang, Yu-Ching Wen, Yen-Nien Liu. Targeting PKLR/MYCN/ROMO1 signaling suppresses neuroendocrine differentiation of castration-resistant prostate cancerRedox Biology 2023; 62: 102686 doi: 10.1016/j.redox.2023.102686
12
K. Öberg, A. Califano, J.R. Strosberg, S. Ma, U. Pape, L. Bodei, G. Kaltsas, C. Toumpanakis, J.R. Goldenring, A. Frilling, S. Paulson. A meta-analysis of the accuracy of a neuroendocrine tumor mRNA genomic biomarker (NETest) in bloodAnnals of Oncology 2020; 31(2): 202 doi: 10.1016/j.annonc.2019.11.003
13
Annamária Kövesdi, Petra Anna Kurucz, Gábor Nyírő, Ottó Darvasi, Attila Patócs, Henriett Butz. Circulating miRNA Increases the Diagnostic Accuracy of Chromogranin A in Metastatic Pancreatic Neuroendocrine TumorsCancers 2020; 12(9): 2488 doi: 10.3390/cancers12092488
14
Shane Quo, Wisam Zakko. A Case of Functional Bowel Disease Misdiagnosed as Carcinoid SyndromeACG Case Reports Journal 2023; 10(9): e01136 doi: 10.14309/crj.0000000000001136
15
Ivaylo Stefanov Stefanov, Stefan Ivaylov Stefanov, Maya Vladova Gulubova. Glucagon- and insulin-immunopositive endocrine cells in porcine extrahepatic bile ducts and gallbladderFrontiers in Veterinary Science 2023; 10 doi: 10.3389/fvets.2023.1240143
16
Jaume Trapé, Esther Fernández-Galán, Josep Maria Auge, Marina Carbonell-Prat, Xavier Filella, Sílvia Miró-Cañís, Carolina González-Fernández, Stefan Holdenrieder, Huub van Rossum, Michel van den Heuvel. Factors influencing blood tumor marker concentrations in the absence of neoplasiaTumor Biology 2024; 46(s1): S35 doi: 10.3233/TUB-220023
17
Helen L. Robbins, Megan Symington, Barbara Mosterman, Fiona Tranter, Louise Davies, Harpal S. Randeva, Ana Penedo, Clara Ferreira, Catherine Darby, Dimitri Grammatopoulos, Gregory Kaltsas, Martin O. Weickert. Effects of intake of breakfast or caffeine-containing beverages on measurement of circulating chromogranin A in plasmaGastroHep 2019; 1(1): 11 doi: 10.1002/ygh2.208
18
Kade C. Flowers, Kate E. Shipman. Pitfalls in the Diagnosis and Management of Hypercortisolism (Cushing Syndrome) in Humans; A Review of the Laboratory Medicine PerspectiveDiagnostics 2023; 13(8): 1415 doi: 10.3390/diagnostics13081415
19
Sarath S. Joseph, Dan H. V. Tran, Farhadul Islam, Vinod Gopalan. Current Cancer Biomarkers2023; : 148 doi: 10.2174/9789815079364123010011
20
Oana Ciobanu, Sorina Martin, Simona Fica. Perspectives on the diagnostic, predictive and prognostic markers of neuroendocrine neoplasms (Review)Experimental and Therapeutic Medicine 2021; 22(6) doi: 10.3892/etm.2021.10914
21
Oksana Novikova, Olga Sidorenko, Galina Bozhok, Tatyana Bondarenko. Cryopreservation Effect on Chromogranin A Expression in Neonatal Pig Adrenal Cell CultureProblems of Cryobiology and Cryomedicine 2019; 29(4): 344 doi: 10.15407/cryo29.04.344
22
Anja C. Roden, Julian R. Molina. Plasma Biomarkers to Monitor Bronchopulmonary Carcinoids—Are We There Yet?Journal of Thoracic Oncology 2023; 18(3): 257 doi: 10.1016/j.jtho.2022.12.008
23
Hossein Yahyazadeh, Marzieh Beheshti, Sahel Valadan Tahbaz. Gastrointestinal Neuroendocrine Tumours: A Single-Centre ExperienceForum of Clinical Oncology 2022; 13(1): 3 doi: 10.2478/fco-2022-0004
24
Michele Bevere, Francesca Masetto, Maria Elena Carazzolo, Alice Bettega, Anastasios Gkountakos, Aldo Scarpa, Michele Simbolo. An Overview of Circulating Biomarkers in Neuroendocrine Neoplasms: A Clinical GuideDiagnostics 2023; 13(17): 2820 doi: 10.3390/diagnostics13172820
25
N. V. Lyubimova, Yu. S. Timofeev, T. K. Churikova, A. A. Markovich, G. S. Emelianova, I. S. Stilidi, N. E. Kushlinskii. Chromogranin A and serotonin for evaluation of treatment efficacy of neuroendocrine tumorsAlmanac of Clinical Medicine 2020; 47(8): 685 doi: 10.18786/2072-0505-2019-47-054
26
T Szarvas, B Jardin-Watelet, N Bourgoin, M J Hoffmann, P Nyirády, C Oláh, T Széll, A Csizmarik, B Hadaschik, H Reis. High-soluble CGA levels are associated with poor survival in bladder cancerEndocrine Connections 2019; 8(5): 625 doi: 10.1530/EC-19-0068
27
Salman Syed, Spyridon P. Basourakos, Faisal S. Ali, Jessica L. Garcia, Amado Zurita-Saavedra, Zimu Gong. A Limited-Versus-Extensive Staging Strategy for Small Cell Prostate CancerAmerican Journal of Clinical Oncology 2020; 43(2): 87 doi: 10.1097/COC.0000000000000631
28
Jack Cope, Rory Maclean, Shweta Hota, John K. Ramage, Nicola Mullholland, Dominique Clement, Sarah Brown, Sue Piper, Phil MaCarthy, Olaf Wendler, Raj Srirajaskanthan. Improving outcomes in carcinoid heart disease – learning from a single centreNuclear Medicine Communications 2023; 44(11): 968 doi: 10.1097/MNM.0000000000001749
29
Juliette M Kassas, Julia V Fiuk, Carol A Brenner. Primary Small Cell Carcinoma of the BladderCureus 2021;  doi: 10.7759/cureus.15146
30
Anna Malczewska, Mark Kidd, Somer Matar, Beata Kos-Kudła, Lisa Bodei, Kjell Oberg, Irvin M. Modlin. An Assessment of Circulating Chromogranin A as a Biomarker of Bronchopulmonary Neuroendocrine Neoplasia: A Systematic Review and Meta-AnalysisNeuroendocrinology 2020; 110(3-4): 198 doi: 10.1159/000500525
31
Hossein Safarpour, Javad Ranjbaran, Nafiseh Erfanian, Samira Nomiri, Afshin Derakhshani, Casimiro Gerarduzzi, Adib Miraki Feriz, Edris HosseiniGol, Samira Saghafi, Nicola Silvestris. Holistic exploration of CHGA and hsa-miR-137 in colorectal cancer via multi-omic data IntegrationHeliyon 2024; 10(5): e27046 doi: 10.1016/j.heliyon.2024.e27046
32
Diana Loreta Paun, Alexandra Mirica. Pheochromocytoma, Paraganglioma and Neuroblastoma2021;  doi: 10.5772/intechopen.95888
33
Raja Pramanik, Aparna Sharma. Onco-critical Care2022; : 263 doi: 10.1007/978-981-16-9929-0_23
34
Matthew Philip Davies, Thomas William John Evans, Fawzia Tahir, Saba P. Balasubramanian. Parathyroid cancer: A systematic review of diagnostic biomarkersThe Surgeon 2021; 19(6): e536 doi: 10.1016/j.surge.2021.01.011